UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Barrow Hanley Mewhinney & Strauss LLC

Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 716,647 shares of the healthcare conglomerate's stock after purchasing an additional 21,402 shares during the quarter. Barrow Hanley Mewhinney & Strauss LLC owned 0.08% of UnitedHealth Group worth $362,523,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the stock. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $30,000. Promus Capital LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $32,000. Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $40,000. Finally, Legacy Investment Solutions LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $57,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.33% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on UNH shares. KeyCorp reaffirmed an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Stock Up 1.6 %

NYSE UNH traded up $8.44 during trading hours on Monday, reaching $524.48. 5,236,968 shares of the company traded hands, compared to its average volume of 4,272,844. The stock has a market capitalization of $479.75 billion, a PE ratio of 33.84, a PEG ratio of 1.37 and a beta of 0.62. The company has a 50 day moving average of $508.81 and a two-hundred day moving average of $543.92. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the business posted $5.83 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.